Immutep Limited, Level 32, Australia Square, 264 George Street, Sydney NSW 2000, Australia; ABN: 90 009 237 889 Audit and Risk Committee Update – ASX Listing Rules 12.7 SYDNEY, AUSTRALIA – 9 October 2026 – Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”)...
Audit and Risk Committee Update
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Immutep
- Final Director's Interest Notice - P Meyers
- Notification of cessation of securities - IMM
- Resignation of Non-Executive Director
- Change of Director's Interest Notice - P Meyers
- Application for quotation of securities - IMM
Later from Immutep
- Immutep Regains Compliance with Nasdaq
- Immutep & Monash Secure Further ARC Funding for LAG-3
- 2026 Annual General Meeting and Key Dates
- Late-Breaking Abstract on IMP761 to be presented at ACR 2026
- Quality of Life Data from EFTISARC-NEO presented at ESMO
Follow Immutep into a list and get an email when it puts out news.
Follow Immutep